Your browser doesn't support javascript.
loading
Type II Heparin-Induced Thrombocytopenia Manifesting As Cardiac Arrest Following Intravenous Heparin Bolus During an Elective Procedure: A Case Report and Literature Review.
Nepal, Nisha; Patel, Dhiraj; Omosebi, Opeyemi; Shin, Yong.
Affiliation
  • Nepal N; Internal Medicine, Danbury Hospital, Danbury, USA.
  • Patel D; Internal Medicine, University of Vermont, Burlington, USA.
  • Omosebi O; Internal Medicine, Connecticut Institute For Communities, Inc., Danbury, USA.
  • Shin Y; Medicine, Danbury Hospital, Danbury, USA.
Cureus ; 16(3): e57072, 2024 Mar.
Article de En | MEDLINE | ID: mdl-38681320
ABSTRACT
Heparin-induced thrombocytopenia (HIT) is a rare and life-threatening autoimmune-mediated adverse drug reaction seen in patients who are exposed to various forms of pharmacological heparin, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH). Despite the presence of thrombocytopenia, these patients face the risk of clot formation and bleeding simultaneously. Prompt cessation of heparin and the initiation of non-heparin anticoagulants are important for the patient's survival. Typically, clinical diagnosis of HIT is necessary, and waiting for lab test results, which can take days, may not be always feasible. Here, we present a case of an unusual presentation of type II HIT, complicated by significant thrombocytopenia, pulmonary hemorrhage, and cardiac arrest after receiving intravenous (IV) heparin bolus during an elective cardiac ablation procedure for paroxysmal atrial fibrillation.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Cureus Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Cureus Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique